William Love
Founder at DESTINY PHARMA PLC
Net worth: 1 M $ as of 2024-04-29
William Love active positions
Companies | Position | Start | End |
---|---|---|---|
DESTINY PHARMA PLC | Director/Board Member | 2017-04-30 | - |
Chief Tech/Sci/R&D Officer | 2017-04-12 | - | |
Founder | 1996-03-03 | - | |
Chief Executive Officer | 1996-03-03 | 2017-01-19 |
Career history of William Love
Former positions of William Love
Companies | Position | Start | End |
---|---|---|---|
Beam Alliance
Beam Alliance Pharmaceuticals: MajorHealth Technology Beam Alliance is a French company that collaborates with the existing community of stakeholders to foster tangible policies and incentives for the discovery and development of novel antibacterial therapies and diagnostics. The private company is based in Paris, France. The company is aware of the problem arising from the lack of differentiation between different antimicrobials and has set up a dedicated scientific team, namely the Beam Task Force - E (BTF-E), to tackle the issue and propose solutions for better evaluating antimicrobial efficacy within a regulatory context. The company was founded by Florence Séjourné. | Corporate Officer/Principal | - | - |
Statistics
International
United Kingdom | 2 |
France | 2 |
Operational
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sectoral
Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
DESTINY PHARMA PLC | Health Technology |
Private companies | 1 |
---|---|
Beam Alliance
Beam Alliance Pharmaceuticals: MajorHealth Technology Beam Alliance is a French company that collaborates with the existing community of stakeholders to foster tangible policies and incentives for the discovery and development of novel antibacterial therapies and diagnostics. The private company is based in Paris, France. The company is aware of the problem arising from the lack of differentiation between different antimicrobials and has set up a dedicated scientific team, namely the Beam Task Force - E (BTF-E), to tackle the issue and propose solutions for better evaluating antimicrobial efficacy within a regulatory context. The company was founded by Florence Séjourné. | Health Technology |
- Stock Market
- Insiders
- William Love
- Experience